-
公开(公告)号：US20120143656A1
公开(公告)日：2012-06-07
申请号：US13149800
申请日：2011-05-31
申请人： Brendan Murphy
发明人： Brendan Murphy
IPC分类号： G06Q30/02
CPC分类号： G06Q30/0207 , G06Q30/0283 , G06Q30/0605 , G06Q50/01
摘要： Embodiments of the invention are directed to group aggregation leveraging methods and systems for consumers to buy products from a broker. The broker offers a product to consumers for a first fixed price for a predetermined time period. Once a predetermined number of consumers commit to purchasing the product (i.e., reach a threshold), the consumers receive the same product at a second fixed price wherein the second fixed price is less than the first fixed price. Once the threshold is met, each committed consumer receives an alert from the broker that the consumer will receive the same product at the new reduced price (second fixed price). This process is repeated until the predetermined time period expires or inventory of the product is depleted. Consumers may leverage their collective group buying power by communicating to others that the product is available for the predetermined time period through social media or any other suitable means.
摘要翻译： 本发明的实施例涉及用于消费者从经纪商购买产品的组聚合方法和系统。 经纪人在预定时间内向消费者提供第一固定价格的产品。 一旦预定数量的消费者承诺购买产品（即达到阈值），则消费者以第二固定价格接收相同的产品，其中第二固定价格小于第一固定价格。 一旦满足阈值，每个承诺的消费者从经纪人收到一个警报，消费者将以新的降价（第二固定价格）收到相同的产品。 重复该过程直到预定时间段到期或产品的库存耗尽。 消费者可以通过与其他人沟通，通过社交媒体或任何其他合适的方式在预定的时间段内提供产品来利用其集体购买力。
-
公开(公告)号：US07070811B2
公开(公告)日：2006-07-04
申请号：US11190393
申请日：2005-07-26
CPC分类号： A61K31/7052 , A61K9/2018 , A61K9/2054 , A61K9/2095
摘要： The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient.This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet.Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin.This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.
-
公开(公告)号：USD956429S1
公开(公告)日：2022-07-05
申请号：US29706772
申请日：2019-09-24
申请人： Brendan Murphy , Neil Murphy
设计人： Brendan Murphy , Neil Murphy
-
公开(公告)号：US20060129484A1
公开(公告)日：2006-06-15
申请号：US10524113
申请日：2003-09-05
IPC分类号： G06Q40/00
CPC分类号： G06Q20/18 , G06Q20/102 , G06Q20/4014 , G06Q30/06 , G07F9/02 , G07F19/20 , G07F19/202 , G07F19/207
摘要： This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.
摘要翻译： 本发明提供了在车间，后台和现金转运场所的支付媒体处理过程中最小化或消除人为干预的系统和方法。 通过自动化流程并提供用于传送支付媒体的物理，篡改的明显的安全手段，可以限制（如果不消除）零售人员处理支付媒体的需要本发明还提供了使零售商能够统计， 以商业银行可接受的格式调节和准备付款媒体。 本发明还提供了用于安全审计跟踪的系统和方法，其详细说明从支付媒体始发来源到银行的支付媒体移动。
-
公开(公告)号：US20050013835A1
公开(公告)日：2005-01-20
申请号：US10636013
申请日：2003-08-06
IPC分类号： A61K9/10 , A61K9/00 , A61K31/7042 , A61K31/7048 , A61K47/04 , A61K47/26 , A61K47/36 , A61K47/38 , A61K47/46 , A61K9/14
CPC分类号： A61K9/0095 , A61K31/7048
摘要： This invention relates to a powder for oral suspension, and an oral suspension made therefrom, which comprises non-dihydrate azithromycin and an azithromycin conversion stabilizing excipient, wherein said excipient reduces the conversion of the form of azithromycin, when placed in suspension, to another form of azithromycin. This invention further relates to a method for reducing the conversion of a form of non-dihydrate azithromycin, in an oral suspension, by adding a surface tension reducing excipient that reduces the surface tension of the aqueous vehicle. Furthermore, this invention relates to a method for reducing the conversion of a non-dihydrate azithromycin, in an unflavored oral suspension, by raising the viscosity of the oral suspension, and in a flavored oral suspension by lowering the viscosity of the oral suspension.
摘要翻译： 本发明涉及用于口服悬浮液的粉末和由其制备的口服悬浮液，其包含非二水合阿奇霉素和阿奇霉素转化稳定赋形剂，其中所述赋形剂将阿奇霉素的形式在悬浮液中降低至另一种形式 的阿奇霉素。 本发明还涉及通过添加降低水性载体的表面张力的降低表面张力的赋形剂来减少口服悬浮液中的非二水合阿奇霉素形式的转化的方法。 此外，本发明涉及通过提高口腔悬浮液的粘度和通过降低口服悬浮液的粘度而在调味的口服悬浮液中降低非风味口服悬浮液中的非二水合阿奇霉素的转化率的方法。
-
公开(公告)号：US20060146839A1
公开(公告)日：2006-07-06
申请号：US10524110
申请日：2003-09-05
IPC分类号： H04L12/56
CPC分类号： G06Q20/06
摘要： This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.
摘要翻译： 本发明提供了在车间，后台和现金转运场所的支付媒体处理过程中最小化或消除人为干预的系统和方法。 通过自动化流程并提供用于传送支付媒体的物理，篡改的明显的安全手段，可以限制（如果不消除）零售人员处理支付媒体的需要本发明还提供了使零售商能够统计， 以商业银行可接受的格式调节和准备付款媒体。 本发明还提供了用于安全审计跟踪的系统和方法，其详细说明从支付媒体始发来源到银行的支付媒体移动。
-
公开(公告)号：US20060112006A1
公开(公告)日：2006-05-25
申请号：US10524109
申请日：2003-09-05
申请人： Harlan Hurwitz , Stewart Kautsch , Brendan Murphy , Robert Pickles , Daniel Wobser , Darren Taylor
发明人： Harlan Hurwitz , Stewart Kautsch , Brendan Murphy , Robert Pickles , Daniel Wobser , Darren Taylor
IPC分类号： G06Q40/00
CPC分类号： G07F19/201 , G06Q20/102 , G06Q30/06 , G06Q40/02 , G07F9/02 , G07F19/20
摘要： This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media. This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.
摘要翻译： 本发明提供了在车间，后台和现金转运场所的支付媒体处理过程中最小化或消除人为干预的系统和方法。 通过自动化流程并提供用于运输支付媒体的物理，篡改的安全手段，可以限制（如果不是除去）零售人员处理支付媒体的需要。 本发明还提供使零售商能够以商业银行可接受的格式对支付媒体进行计数，协调和准备的系统和方法。 本发明还提供了用于安全审计跟踪的系统和方法，其详细说明从支付媒体始发来源到银行的支付媒体移动。
-
公开(公告)号：US20060106716A1
公开(公告)日：2006-05-18
申请号：US10524111
申请日：2003-09-05
IPC分类号： G06Q40/00
CPC分类号： G06Q30/00 , G06Q20/102
摘要： This invention provides systems and methods that minimize or remove human intervention during the payment media handling process on the shop floor, in the back office and at the cash-in-transit place. By automating processes and providing physical, tamper evident secure means for transporting the payment media, it is possible to limit, if not remove, the need for retail staff to handle payment media This invention also provides systems and methods that enable the retailer to count, reconcile and prepare the payment media in a format that is acceptable to the commercial banks. This invention further provides systems and methods for a secure audit trail that detail payment media movement from the payment media originating source to the bank.
摘要翻译： 本发明提供了在车间，后台和现金转运场所的支付媒体处理过程中最小化或消除人为干预的系统和方法。 通过自动化流程并提供用于传送支付媒体的物理，篡改的明显的安全手段，可以限制（如果不消除）零售人员处理支付媒体的需要本发明还提供了使零售商能够统计， 以商业银行可接受的格式调节和准备付款媒体。 本发明还提供了用于安全审计跟踪的系统和方法，其详细说明从支付媒体始发来源到银行的支付媒体移动。
-
公开(公告)号：US20060024363A1
公开(公告)日：2006-02-02
申请号：US11212332
申请日：2005-08-26
申请人： Brendan Murphy , Steven Collier , Ernest Quan , Barbara Johnson
发明人： Brendan Murphy , Steven Collier , Ernest Quan , Barbara Johnson
IPC分类号： A61K9/20 , A61K31/7052
CPC分类号： A61K31/7052 , A61K9/2018 , A61K9/2054 , A61K9/2095
摘要： The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.
-
公开(公告)号：US20050287209A1
公开(公告)日：2005-12-29
申请号：US11190393
申请日：2005-07-26
申请人： Brendan Murphy , Steven Collier , Ernest Quan , Barbara Johnson
发明人： Brendan Murphy , Steven Collier , Ernest Quan , Barbara Johnson
IPC分类号： A61K9/20 , A61K31/7052
CPC分类号： A61K31/7052 , A61K9/2018 , A61K9/2054 , A61K9/2095
摘要： The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.
摘要翻译： 本发明涉及用于通过直接压制形成阿奇霉素片剂的干混物，其包含非二水合阿奇霉素和至少一种药学上可接受的赋形剂。 本发明还涉及包含非二水合阿奇霉素和至少一种药学上可接受的赋形剂的阿奇霉素片剂。 优选地，阿奇霉素片剂通过直接压制本发明的干混物形成，形成所述阿奇霉素片剂。 优选地，本发明的阿奇霉素片剂含有250mgA，500mgA或600mgA阿奇霉素的剂量。 本发明还涉及阿奇霉素片剂，其通过形成无颗粒状阿奇霉素A型和至少一种药学上可接受的赋形剂的干混合物而制备。 然后通过直接压制干混合物形成阿奇霉素片。
-
-
-
-
-
-
-
-
-
搜索结果
14 条记录 (耗时 0.023 秒)